Coeptis Therapeutics Holdings Inc – Quartalsfinanzdaten (NASDAQ:COEP)

Financials

Mittelzufluss aus laufender Geschäftstätigkeit -1.44 M-2.37 M-2.4 M-2.15 M-1.69 M -8.6 M Mittelzufluss aus Investitionstätigkeit 100 K0000 0 Zahlungsströme aus der Finanzierungstätigkeit 731.97 K6.1 M125.1 K5.06 M2.45 M 13.74 M Freier Cashflow -1.44 M-2.37 M-2.4 M-2.15 M-1.69 M -8.6 M

COEP

Financials

Nachrichten

NASDAQ rügt Coeptis Therapeutics wegen verspäteter Hauptversammlung

Coeptis Therapeutics receives Nasdaq notice for delayed annual meeting

Coeptis Therapeutics extinguishes convertible debt with Yorkville

Coeptis (COEP) Announces Filing of Registration Statement on Form S-4 with SEC in Connection with Proposed Transaction with Z Squared

SNAP Biosciences licenses Monarch’s cell therapy tech

Crude Oil Edges Higher; Phillips 66 Posts Wider-Than-Expected Loss - Coursera (NYSE:COUR), Coeptis Therapeutics (NASDAQ:COEP)

Dow Falls 200 Points; Alphabet Posts Upbeat Q1 Results - Azul (NYSE:AZUL), AGM Gr Hldgs (NASDAQ:AGMH)